ChromaDex, based in Irvine, Calif., has named Jeffrey Himmel its new CEO. Previous CEO Frank Jaksch will assume the position of chief scientific officer and remain on the ChromaDex board of directors.
Himmel also has agreed to invest $1 million in ChromaDex.
Himmel previously has held positions at Rothschild and Jeffrey Martin, an over-the-counter pharmaceutical company founded by his father, Martin Himmel. He also is the former chairman of The Himmel Group and currently serves as a member of the board of directors of The Consumer Healthcare Products Association.